Myocardium injury biomarkers predict prognosis of critically ill coronavirus disease 2019 (COVID-19) patients
Liang Cao(Chinese Academy of Medical Sciences & Peking Union Medical College), Haitao Liu(Harbin Medical University), Zhe Li(Shanghai Institute of Technology), Feng Li(Guangzhou Eighth People's Hospital), Xi Luo(Chinese Academy of Sciences), Sha Zhang(Xijing Hospital), Yang Bai(Hunan University of Traditional Chinese Medicine), Enxin Wang(National Clinical Research Center for Digestive Diseases), Jing Ma(Tsinghua University)
Cited by 9
Related Papers
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
|Emerging Microbes & Infections|2020|536
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial
|The Lancet. Gastroenterology & hepatology|2019|230